Use of SGLT-2 Inhibitors in Patients With Chronic Kidney Disease
Read this article to explore the growing usage and practical aspects of prescribing SGLT-2 inhibitors for patients suffering from chronic kidney disease.
Exploring the Intersection of SGLT2 Inhibitors and Kidney Disease
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are one of the current emerging therapies to prevent the progression of kidney disease.
Sodium-Glucose Transport Protein 2 Inhibitors - Mechanism of Action, Indications, and Adverse Effects
Sodium-glucose transport Protein 2 (SGLT2) inhibitors mediate glucose transport. The article discusses the use of SGLT2 inhibitors in type 2 diabetes mellitus.
